Response of Human Liver Tissue to Innate Immune Stimuli

Area of Science:

• Immunology
• Hepatology
• Preclinical Research

Background:

• Precision-cut human liver slice cultures (PCLS) are valuable for immunological studies.
• Investigating innate immunity in liver disease models is crucial for understanding pathogenesis and treatment efficacy.

Purpose of the Study:

• To evaluate PCLS capacity in modeling innate immune responses.
• To compare immune responses in normal, chronic HCV-infected, and DAA-cured HCV liver tissues.
• To identify immune dysregulation in Hepatitis C Virus (HCV) infection and its resolution.

Main Methods:

• Utilized precision-cut human liver slice cultures (PCLS) from healthy donors, chronic HCV patients, and DAA-cured HCV patients.
• Stimulated PCLS with Toll-like receptor 3 (TLR3) agonist (poly-I:C) and TLR4 agonist (LPS).
• Assessed innate immune gene expression via direct ex vivo measurements and post-stimulation assays.

Main Results:

• Hepatic innate immunity was enhanced, not suppressed, in HCV-infected liver tissue compared to healthy controls.
• DAA-cured liver tissue exhibited sustained abnormalities in immune gene expression, indicating ongoing immune dysregulation post-HCV elimination.
• Upregulated genes in chronic HCV were primarily associated with non-parenchymal liver cells.

Conclusions:

• PCLS are effective for studying liver pathology and innate immunity.
• Chronic HCV infection enhances hepatic innate immune responses.
• Direct-Acting Antiviral therapy cures HCV but leaves residual immune abnormalities in liver tissue.